Edwards Life (EW) Position Has Raised by Baxter Bros Inc; Orrstown Financial Services Decreased Its Position in Schlumberger LTD Com (SLB) by $649,308 as Shares Declined

December 8, 2017 - By Ellis Scott

Baxter Bros Inc increased its stake in Edwards Life (EW) by 44.97% based on its latest 2017Q2 regulatory filing with the SEC. Baxter Bros Inc bought 8,050 shares as the company’s stock rose 25.80% with the market. The institutional investor held 25,949 shares of the industrial specialties company at the end of 2017Q2, valued at $3.07M, up from 17,899 at the end of the previous reported quarter. Baxter Bros Inc who had been investing in Edwards Life for a number of months, seems to be bullish on the $24.86 billion market cap company. The stock increased 3.61% or $4.09 during the last trading session, reaching $117.45. About 2.26 million shares traded or 45.89% up from the average. Edwards Lifesciences Corporation (NYSE:EW) has risen 15.41% since December 8, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

Orrstown Financial Services Inc decreased its stake in Schlumberger Ltd Com (SLB) by 96.46% based on its latest 2017Q2 regulatory filing with the SEC. Orrstown Financial Services Inc sold 9,838 shares as the company’s stock declined 11.04% while stock markets rallied. The institutional investor held 361 shares of the oilfield services and equipment company at the end of 2017Q2, valued at $24,000, down from 10,199 at the end of the previous reported quarter. Orrstown Financial Services Inc who had been investing in Schlumberger Ltd Com for a number of months, seems to be less bullish one the $85.98 billion market cap company. It closed at $62.07 lastly. It is down 3.30% since December 8, 2016 and is downtrending. It has underperformed by 20.00% the S&P500.

Among 27 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 6 Hold. Therefore 74% are positive. Edwards Lifesciences Corp has $195 highest and $86 lowest target. $121.15’s average target is 3.15% above currents $117.45 stock price. Edwards Lifesciences Corp had 86 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Thursday, June 29. The rating was maintained by Barclays Capital with “Equal-Weight” on Wednesday, October 25. The firm earned “Buy” rating on Friday, September 1 by RBC Capital Markets. The company was upgraded on Tuesday, November 8 by Northland Capital. The company was initiated on Tuesday, September 22 by UBS. The firm has “Buy” rating by SunTrust given on Thursday, January 21. JP Morgan maintained Edwards Lifesciences Corporation (NYSE:EW) on Monday, April 11 with “Overweight” rating. Citigroup initiated Edwards Lifesciences Corporation (NYSE:EW) rating on Thursday, November 12. Citigroup has “Sell” rating and $134 target. The rating was upgraded by Bank of America to “Buy” on Wednesday, July 27. The rating was upgraded by Bank of America to “Buy” on Thursday, July 27.

Baxter Bros Inc, which manages about $372.05M and $332.19 million US Long portfolio, decreased its stake in Air Prods & Chems (NYSE:APD) by 3,760 shares to 13,243 shares, valued at $1.90M in 2017Q2, according to the filing.

More recent Edwards Lifesciences Corporation (NYSE:EW) news were published by: Seekingalpha.com which released: “Buy Edwards Lifesciences: Weak Third-Quarter Performance Is Just A Blip On A …” on November 17, 2017. Also Seekingalpha.com published the news titled: “Edwards Lifesciences buys Harpoon Medical for $100M” on December 06, 2017. Zacks.com‘s news article titled: “Edwards Lifesciences’ Pipeline Strong Amid Rising Expenses” with publication date: November 28, 2017 was also an interesting one.

Among 35 analysts covering Schlumberger Limited. (NYSE:SLB), 27 have Buy rating, 1 Sell and 7 Hold. Therefore 77% are positive. Schlumberger Limited. had 123 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co with “Outperform” on Monday, April 25. The firm has “Buy” rating given on Friday, April 7 by Jefferies. The firm earned “Buy” rating on Thursday, July 20 by RBC Capital Markets. Bernstein initiated Schlumberger Limited (NYSE:SLB) on Friday, December 2 with “Mkt Perform” rating. Barclays Capital upgraded Schlumberger Limited (NYSE:SLB) rating on Wednesday, April 20. Barclays Capital has “Overweight” rating and $93 target. The firm earned “Buy” rating on Friday, June 30 by Jefferies. The firm has “Buy” rating by RBC Capital Markets given on Friday, October 6. KLR Group initiated Schlumberger Limited (NYSE:SLB) on Monday, December 14 with “Buy” rating. Suntrust Robinson initiated the shares of SLB in report on Wednesday, January 18 with “Hold” rating. The rating was maintained by JP Morgan with “Overweight” on Tuesday, September 12.

More news for Schlumberger Limited (NYSE:SLB) were recently published by: Businesswire.com, which released: “Schlumberger Announces Fourth-Quarter and Full-Year 2017 Results Conference Call” on November 29, 2017. Seekingalpha.com‘s article titled: “Schlumberger: Breaking Down” and published on November 17, 2017 is yet another important article.

Since June 12, 2017, it had 0 insider buys, and 1 sale for $2.77 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: